ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,441Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 35

$541K Total Retail Price of All Prescriptions

Rank: 15 out of 35

450 Patients Receiving at Least One Drug in Part D
98%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 450 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

16% of this provider’s 450 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 12,420 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 33.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 579 579 1 3
AMLODIPINE BESYLATE 556 556 2 9
SIMVASTATIN 492 492 3 6
FUROSEMIDE 475 475 4 1
OMEPRAZOLE 438 438 5 4
LISINOPRIL 399 392 6 5
HYDROCODONE-ACETAMINOPHEN 386 386 S3 7 2
HYDROCHLOROTHIAZIDE 306 306 8 22
WARFARIN SODIUM 278 271 9 8
METOPROLOL SUCCINATE 252 252 10 20
LOSARTAN POTASSIUM 247 247 11 38
GABAPENTIN 234 234 12 14
METOPROLOL TARTRATE 231 231 13 11
METFORMIN HCL 221 221 14 19
CITALOPRAM HBR 191 191 15 13
DONEPEZIL HCL 189 189 16 7
ATENOLOL 181 181 17 31
NAMENDA 165 165 18 12
ATORVASTATIN CALCIUM 162 162 19 28
POTASSIUM CHLORIDE 160 160 20 10
PREDNISONE 128 128 21 36
CIPROFLOXACIN HCL 122 121 22 70
ALENDRONATE SODIUM 117 117 23 33
POLYETHYLENE GLYCOL 3350 116 116 24 15
PRAVASTATIN SODIUM 110 110 25 32
ALLOPURINOL 109 109 26 47
SERTRALINE HCL 97 97 27 18
ESCITALOPRAM OXALATE 94 94 28 30
TAMSULOSIN HCL 90 90 29 29
SULFAMETHOXAZOLE-TRIMETHOPRIM 85 84 30 60
CARVEDILOL 82 82 31 25
ADVAIR DISKUS 76 76 32 46
SPIRONOLACTONE 73 73 33 54
CLOPIDOGREL 72 72 34 34
GEMFIBROZIL 72 72 34 198
CLONIDINE HCL 71 71 36 76
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 71 36 93
DIOVAN 68 68 38 66
TRAMADOL HCL 67 67 39 24
DIGOXIN 66 66 40 49
MIRTAZAPINE 66 66 40 16
AZITHROMYCIN 65 65 42 57
GLIPIZIDE 62 62 43 68
LABETALOL HCL 60 60 44 294
SYNTHROID 59 59 45 136
OXYCODONE-ACETAMINOPHEN 58 58 S2 46 78
NYSTATIN 57 57 47 44
ISOSORBIDE MONONITRATE ER 56 56 48 43
JANTOVEN 55 54 49 204
PROPRANOLOL HCL 54 54 50 102
DILTIAZEM 24HR CD 53 53 51 87
FLUTICASONE PROPIONATE 52 52 52 62
DIOVAN HCT 52 52 52 192
FLUOXETINE HCL 52 52 52 63
CARBIDOPA-LEVODOPA 51 51 55 48
SPIRIVA 51 51 55 61
FENTANYL 51 51 S2 55 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.